SCHEMBL31639320

SCHEMBL31639320

COc1cc2ncc(-c3nc(Cl)c(C#N)cc3F)n2nc1N1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ CLK1 P49759 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ EGLN2 Q96KS0 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ SRC P12931 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ LRRK2 Q5S007 3/20 0.36
▸ BCL6 P41182 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31639312 1.00 ALDH1A1 (0.41) ALDH1A1KMT2APOLBCLK1RXFP1
SCHEMBL31639429 0.83 TGFBR1 (0.35) EGLN2SRCLRRK2EGFRERBB2
SCHEMBL31639498 0.83 TGFBR1 (0.35) EGLN2SRCLRRK2EGFRERBB2
SCHEMBL31639125 0.82 MTOR (0.40) PIK3CAMTORGAASMN1; SMN2BCL6
SCHEMBL31639299 0.80 KHK (0.34) EGLN2SRCLRRK2EGFRERBB2
SCHEMBL31000250 0.80 GAA (0.41) PIK3CAMTORGAASMN1; SMN2BCL6
SCHEMBL31639610 0.79 NRAS (0.39) ALDH1A1EGLN2LRRK2
SCHEMBL31639298 0.79 GABRA1 (0.35) EGLN2SRCEGFRERBB2
SCHEMBL31639270 0.77 EGFR (0.33) EGLN2SRCLRRK2EGFRERBB2
SCHEMBL15638502 0.72 MAPK1 (0.52) ALDH1A1KMT2APOLBCLK1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137567-A1 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2025-06-26 — — WO disclosed
Send feedback